Vespa J, Medina L, Armstrong DM. Demographic turning points for the United States: population projections for 2020 to 2060. Current Population Reports. U.S. Census; 2020. pp. 25–1144.
U.S. Department of Health and Human Services. National plan to address alzheimer’s disease: 2016 update. 2016. pp. 1–70. https://aspe.hhs.gov/reports/national-plan-address-alzheimers-disease-2016-update.
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and Management of the Metabolic Syndrome. Circulation. 2005;112:2735–52. https://doi.org/10.1161/CIRCULATIONAHA.105.169404.
Wang X, Ji L, Tang Z, Ding G, Chen X, Lv J, et al. The association of metabolic syndrome and cognitive impairment in Jidong of China: a cross-sectional study. BMC Endocr Disord. 2021;21:1–8. https://doi.org/10.1186/s12902-021-00705-w.
Ng TP, Feng L, Nyunt MSZ, Feng L, Gao Q, Lim ML, et al. Metabolic syndrome and the risk of mild cognitive impairment and progression to dementia follow-up of the Singapore longitudinal ageing study cohort. JAMA Neurol. 2016;73:456–63. https://doi.org/10.1001/jamaneurol.2015.4899.
Wee J, Sukudom S, Bhat S, Marklund M, Peiris NJ, Hoyos CM, et al. The relationship between midlife dyslipidemia and lifetime incidence of dementia: A systematic review and meta-analysis of cohort studies. Alzheimers Dement (Amst). 2023;15:1–11. https://doi.org/10.1002/dad2.12395.
Yaffe K. The Metabolic Syndrome, Inflammation, and Risk of Cognitive Decline. JAMA. 2004;292:2237. https://doi.org/10.1001/jama.292.18.2237.
Article CAS PubMed Google Scholar
Hirode G, Wong RJ. Trends in the Prevalence of Metabolic Syndrome in the United States, 2011–2016. JAMA. 2020;323:2526. https://doi.org/10.1001/jama.2020.4501.
Article PubMed PubMed Central Google Scholar
Moore JX, Chaudhary N, Akinyemiju T. Metabolic Syndrome Prevalence by Race/Ethnicity and Sex in the United States, National Health and Nutrition Examination Survey, 1988–2012. Prev Chronic Dis. 2017;14:160287. https://doi.org/10.5888/pcd14.160287.
Chojdak-Łukasiewicz J, Dziadkowiak E, Zimny A, Paradowski B. Cerebral small vessel disease: A review. Adv Clin Exp Med. 2021;30:349–56. https://doi.org/10.17219/ACEM/131216.
Zlokovic BV, Gottesman RF, Bernstein KE, Seshadri S, McKee A, Snyder H, et al. Vascular contributions to cognitive impairment and dementia (VCID): A report from the 2018 National Heart, Lung, and Blood Institute and National Institute of Neurological Disorders and Stroke Workshop. Alzheimer’s Dement. 2020;16:1714–33. https://doi.org/10.1002/alz.12157.
Gorelick PB, Scuteri A, Black SE, DeCarli C, Greenberg SM, Iadecola C, et al. Vascular Contributions to Cognitive Impairment and Dementia. Stroke. 2011;42:2672–713. https://doi.org/10.1161/str.0b013e3182299496.
Article PubMed PubMed Central Google Scholar
Viticchi G, Falsetti L, Buratti L, Luzzi S, Bartolini M, Acciarri MC, et al. Metabolic syndrome and cerebrovascular impairment in Alzheimer’s disease. Int J Geriatr Psychiatry. 2015;30:1164–70. https://doi.org/10.1002/gps.4269.
Matić TB, Toncev G, Gavrilović A, Aleksić D. Suffering from cerebral small vessel disease with and without metabolic syndrome. Open Med. 2019;14:479–84. https://doi.org/10.1515/med-2019-0051.
James M, Varghese TP, Sharma R, Chand S. Association Between Metabolic Syndrome and Diabetes Mellitus According to International Diabetic Federation and National Cholesterol Education Program Adult Treatment Panel III Criteria: a Cross-sectional Study. J Diabetes Metab Disord. 2020;19:437–43. https://doi.org/10.1007/s40200-020-00523-2.
Article CAS PubMed PubMed Central Google Scholar
O’Neill S, O’Driscoll L. Metabolic syndrome: A closer look at the growing epidemic and its associated pathologies. Obes Rev. 2015;16:1–12. https://doi.org/10.1111/obr.12229.
Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, et al. The Metabolic Syndrome and Chronic Kidney Disease in U.S. Adults. Ann Intern Med. 2004;140:167. https://doi.org/10.7326/0003-4819-140-3-200402030-00007.
Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12:822–38. https://doi.org/10.1016/S1474-4422(13)70124-8.
Article PubMed PubMed Central Google Scholar
Shi Y, Wardlaw JM. Update on cerebral small vessel disease: A dynamic whole-brain disease. Stroke Vasc Neurol. 2016;1:83–92. https://doi.org/10.1136/svn-2016-000035.
Article PubMed PubMed Central Google Scholar
Sabia S, Elbaz A, Dugravot A, Head J, Shipley M, Hagger-Johnson G, et al. Impact of smoking on cognitive decline in early old age: The Whitehall II cohort study. Arch Gen Psychiatry. 2012;69:627–35. https://doi.org/10.1001/archgenpsychiatry.2011.2016.
Article PubMed PubMed Central Google Scholar
Yaffe K, Barrett-Connor E, Lin F, Grady D. Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol. 2002;59:378–84. https://doi.org/10.1001/archneur.59.3.378.
Amenta F, Mignini F, Rabbia F, Tomassoni D, Veglio F. Protective effect of anti-hypertensive treatment on cognitive function in essential hypertension: Analysis of published clinical data. J Neurol Sci. 2002;203–204:147–51. https://doi.org/10.1016/S0022-510X(02)00281-2.
Moraros J, Nwankwo C, Patten SB, Mousseau DD. The association of antidepressant drug usage with cognitive impairment or dementia, including Alzheimer disease: A systematic review and meta-analysis. Depress Anxiety. 2017;34:217–26. https://doi.org/10.1002/da.22584.
Zuelsdorff M, Okonkwo OC, Norton D, Barnes LL, Graham KL, Clark LR, et al. Stressful Life Events and Racial Disparities in Cognition Among Middle-Aged and Older Adults. J Alzheimer’s Dis. 2020;73:671–82. https://doi.org/10.3233/JAD-190439.
Ng TP, Feng L, Yap KB, Lee TS, Tan CH, Winblad B. Long-Term Metformin Usage and Cognitive Function among Older Adults with Diabetes. J Alzheimer’s Dis. 2014;41:61–8. https://doi.org/10.3233/JAD-131901.
Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: Time for a critical appraisal - Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia. 2005;48:1684–99. https://doi.org/10.1007/s00125-005-1876-2.
Article CAS PubMed Google Scholar
Maria P, Gwee PX, Gao Q, Qian D, Chua L. Metabolic Syndrome and Cognition : Follow-Up Study of Chinese Over-55-Year-Olds. 2020;119228:129–37. https://doi.org/10.1159/000509124.
Bahchevanov KM, Dzhambov AM, Chompalov KA, Massaldjieva RI, Atanassova PA, Mitkov MD. Contribution of Components of Metabolic Syndrome to Cognitive Performance in Middle-Aged Adults. Arch Clin Neuropsychol. 2021;36:498–506. https://doi.org/10.1093/arclin/acaa081.
Reijmer YD, Van Den BE, Dekker JM, Nijpels G, Stehouwer CDA, Kappelle LJ, et al. The metabolic syndrome, atherosclerosis and cognitive functioning in a non-demented population : The Hoorn Study. Atherosclerosis. 2011;219:839–45. https://doi.org/10.1016/j.atherosclerosis.2011.08.032.
Article CAS PubMed Google Scholar
Marseglia A, Darin-Mattsson A, Skoog J, Rydén L, Hadarsson-Bodin T, Kern S, et al. Metabolic Syndrome Is Associated with Poor Cognition: A Population-Based Study of 70-Year-Old Adults without Dementia. Journals Gerontol - Ser A Biol Sci Med Sci. 2021;76:2275–83. https://doi.org/10.1093/gerona/glab195.
Kim YJ, Kim SM, Jeong DH, Lee SK, Ahn ME, Ryu OH. Associations between metabolic syndrome and type of dementia: analysis based on the National Health Insurance Service database of Gangwon province in South Korea. Diabetol Metab Syndr. 2021;13:1–12. https://doi.org/10.1186/s13098-020-00620-5.
Razay G, Vreugdenhil A, Wilcock G. The metabolic syndrome and Alzheimer disease. Arch Neurol. 2007;64:93–6. https://doi.org/10.1001/archneur.64.1.93.
Fan YC, Chou CC, You SL, Sun CA, Chen CJ, Bai CH. Impact of worsened metabolic syndrome on the risk of dementia: A nationwide cohort study. J Am Heart Assoc. 2017;6:1–9. https://doi.org/10.1161/JAHA.116.004749.
留言 (0)